Carolina Venditti

Dr. Carolina Venditti

National Institute for Infectious Diseases (INMI) L. Spallanzani, Rome, Italy
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2012 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
Aurora Garcia-FernandezAurora Garcia-Fernandez
Aurora Garcia-Fernandez
LVLaura Villa
Laura Villa
CCClaudio Carta
Claudio Carta
CVCarolina Venditti
Carolina Venditti
AGAlessandra Giordano
Alessandra Giordano
ACAlessandra Carattoli
Alessandra Carattoli
A carbapenemase-resistant Klebsiella pneumoniae strain, clone ST258 producing KPC-3, was fully characterized. The entire plasmid content was investigated, thereby identifying plasmids of the IncFII k (two of them similar to pKPQIL and pKPN3, respectively), IncX, and ColE types, carrying a formidable set of resistance genes against toxic compounds, metals, and antimicrobial drugs and a novel iron(III) uptake system.

16 October 2012 in Infection
Verified
Journal Article
Closed access
PDF file
GOGiovanni Orsi
Giovanni Orsi
ABA. Bencardino
A. Bencardino
AVAntonio Vena
Antonio Vena
ACAlessandra Carattoli
Alessandra Carattoli
CVCarolina Venditti
Carolina Venditti
MVM. Venditti
M. Venditti

1 February 2019 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
GEG. Errico
G. Errico
CGC. Gagliotti
C. Gagliotti
MMMonica Monaco
Monica Monaco
LML. Masiero
L. Masiero
Paolo GaibaniPaolo Gaibani
Paolo Gaibani
MSM. Salizzoni
M. Salizzoni

1 February 2018 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
EBEvangelo Boumis
Evangelo Boumis
ACAlessandro Capone
Alessandro Capone
VGVincenzo Galati
Vincenzo Galati
CVCarolina Venditti
Carolina Venditti
Nicola PetrosilloNicola Petrosillo
Nicola Petrosillo
In the last decades, probiotics have been widely used as food supplements because of their putative beneficial health effects. They are generally considered safe but rare reports of serious infections caused by bacteria included in the definition of probiotics raise concerns on their potential pathogenic role in patients with particular predisposing factors. Patients with hereditary hemorrhagic telangiectasia (HHT) are exposed to infections because of telangiectasias and arteriovenous malformations (AVMs). We describe what is, to our knowledge, the first case of infective endocarditis (IE) caused by Lactobacillus rhamnosus in a patient with HHT. A systematic review of the relevant medical literature is presented. A patient with HHT and an aortic bioprosthesis was admitted because of prolonged fever not responding to antibiotics. The patient had a history of repeated serious infections with hospitalizations and prolonged use of antibiotics, and used to assume large amounts of different commercial products containing probiotics. Weeks before the onset of symptoms the patient had been treated with nasal packings and with surgical closure of a nasal bleeding site because of recurrent epistaxis. A diagnosis of IE of the aortic bioprosthesis was made. All blood coltures were positive for L. rhamnosus. The patients responded to a cycle of 6 weeks of amoxicillin/clavulanate plus gentamicin. A systematic review of IE linked to consumption of probiotics, and of infective endocarditis in patients with HHT was conducted. 10 cases of IE linked to probiotics consumption and 6 cases of IE in patients with HHT were found. Consumption of probiotics can pose a risk of serious infections in patients with particular predisposing factors. Patients with HHT can be considered at risk because of their predisposition to infections. Prophylaxis with antibiotics before nasal packings in patients with HHT can be considered.

1 May 2011 in Journal of Hospital Infection
Verified
Journal Article
Closed access
GOGiovanni Orsi
Giovanni Orsi
Aurora Garcia-FernandezAurora Garcia-Fernandez
Aurora Garcia-Fernandez
AGA. Giordano
A. Giordano
CVCarolina Venditti
Carolina Venditti
ABA. Bencardino
A. Bencardino
MVMario Venditti
Mario Venditti

1 August 2019 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
MBMonica Basso
Monica Basso
CVCarolina Venditti
Carolina Venditti
GRGiammarco Raponi
Giammarco Raponi
ANAnna Sara Navazio
Anna Sara Navazio
Francesco AlessandriFrancesco Alessandri
Francesco Alessandri
MVMario Venditti
Mario Venditti
The Ralstonia spp. genus is a group of non-fermentative, Gram-negative bacteria often resistant to many antibiotics, which are emerging as opportunistic pathogens frequently associated with infections in hospital settings. We present herein a case of combined R. pickettii and R. mannitolilytica persisting and relapsing bacteraemia, possibly caused by a septic arterial thrombosis secondary to the rupture of an internal carotid artery aneurysm. Microbiology studies showed that both Ralstonia isolates produced biofilm and carried class D oxacillinase genes. When confronted with infections caused by members of the Ralstonia genus, identification to the species level is crucial for correct clinical management, as the two species show different antibiotic susceptibility patterns.